The Life Sciences: THE sector of excellence of the Lyon urban area
3 areas of expertise: infectiology, cancerology, neurosciences
Infectiology: a confirmed leading position
Portal: Lyonbiopole, recognised as a competitiveness cluster in 2005, is a world centre of excellence for diagnostics and vaccines. It has positioned itself as a "factory" for collaborative projects which will develop a health shield against human and animal infectious diseases as well cancer.
Lyonbiopole has been working with scientists, clinics and regional manufacturers (large groups, SMEs and start-ups) in order to set up multi-partner R&D projects aimed at of offering innovative diagnostic, preventative and therapeutic approaches and systems for administering them in order to make medicine more reactive and personalised.
Lyonbiopole also supports the development of small and medium sized companies (R&D, international, Business Development, financing etc.).
Sector leaders: Sanofi Pasteur: World No. 1 in human vaccine, Merial: World No. 1 in veterinary products, bioMérieux: World No. 1 in bacteriological diagnostics.
International research centres: WHO centre for communicable disease surveillance and response systems and a CERVI.
Large establishment: Jean Mérieux P4 laboratory.
A specialised advanced research network (RTRA): Innovation in Infectology (FINOVI), approved in 2006.
Cancerology: a significant expansion of the cluster in Lyon
Portal: the CLARA (Lyon Auvergne Rhône-Alpes cancer hub), centralises and exploits the scientific, clinical and industrial oncology strengths of the Lyon Auvergne Rhône-Alpes region and uses them in research and the manufacture of innovative treatments for patients.
The CLARA has developed along 3 specialist lines of enquiry: (I) Tumour escape, cellular plasticity and targeted therapy, (II) Infections and Cancer, (III) Nanotechnologies, imaging and cancer and there are 3 emerging lines of enquiry: (A) Evaluation, perception of risks and prevention of cancer, (B) Environment, nutrition and cancer and (C) Hadron therapy and cancer. The Testing a Theory programme, which provides funding during the phase before an idea becomes an R&D project that is financed by an innovative business, was created in Lyon thanks to financial support from Greater Lyon.
Hospitals which specialise in cancer: The Léon Bérard regional centre for the fight against cancer, Lyon University hospitals (CHU) with the Haemato-oncology unit in Lyon Sud and the paediatric Haemato Oncology Institute.
International research centres: the CIRC (International Centre for Cancer Research), the CRCL (Lyon Cancer Research Centre).
A specialised research and care network working on particular themes (RTRS): " Synergie Lyon Cancer ", approved early 2007.
The neurosciences: a fast-growing scientific and clinical network
The Rhône-Alpes region is one of the rare centres in Europe to cover all neuroscience and cognitive science fields with exceptional capacity in neuroimaging for human or animal use clinically or in research.
Portal: Specialist research and care network (RTRS) Neurodis, " neurological disability " was approved in 2007. It gathers together researchers and clinicians with international reputations working towards the same medical and scientific objective. This group is to over 800 researchers from Inserm and the CNRS, academics, clinicians, engineers and technicians, doctoral and post doctoral students.
A hospital, unique in Europe, which deals with neurological disorders: The Pierre Wertheimer neurological and neurosurgical hospital of Lyon.
Applied and fundamental research centres: The Lyon centre for neuroscience research (CRNL) and the Institute of cognitive science (ISC).
Specialised technological platforms: A complete multimodal imaging platform, the CERMEP; a platform for the collection of biological samples together with clinical data: NeuroBioTec.
IDEE project for the creation of an Institute specialising in epilepsy, in Lyon (research, care, patients group, manufacturers).
Medical technology, a major business sector
The region has over 300 businesses active in the area of medical technology. This industrial might is a consequence of the cross-fertilisation between the major industrial areas in the Rhône-Alpes region: plastics/health, nanotechnology/health, micromechanics/health, microelectronics/health, optics/health.
Portal: The I-Care (Health Technology Rhône-Alpes Cluster) network aims to support regional businesses in order to put technology and innovation at the disposal of health and health-care and contribute to medical advances. This initiative is addressed to all those in the health technology value chain in the Rhône-Alpes region sub-contractors, producers and distributors, universities, research centres, local authorities, groups, etc.
Life sciences in Lyon: Key figures
Greater Lyon the heart of a dynamic and active region:
- In 4th place in Europe for the number of researchers in the Rhône-Alpes region
- 5% of research capacity at European level is in the Rhône-Alpes region
- 1st ranked European centre for the production of vaccines
- 2nd largest employer in France in the Life Sciences field
Entrepreneurial dynamism:
- 600 companies working in the Life Sciences
- of which 100 are working in biotech/health
- 100,000 jobs in Life Sciences
- Major international groups: Sanofi (Sanofi Pasteur, Mérial, Genzyme Polyclonals), bioMérieux, Merck-Serono, etc.
- SMEs and innovative start-ups: Alaxia, Erytech Pharma, Flamel Technologies, genOway, Imaxio, Edelris, PX'Therapeutics, etc.
- Over 1bn € of investment in vaccines and diagnostics between 2004 and 2010.
2nd largest French region in terms of public and private research capacity:
- Large research pool and higher education facilities:
- 150 academic research laboratories
- 2,000 researchers in infectology (half private/half public)
- 9,000 jobs, 15,000 Life Sciences students and 150 new doctorates per year
- 55 million € in technology transfer per year
- 350 clinical studies in public and private care establishments and University Hospital Centres (CHU)
- 4,000 researchers in the nanotechnology sector of which 300 specialises in health applications (CEA, LETI, etc.) in Grenoble
Large hospital facilities:
- 40 hospitals
- The Hospices Civils de Lyon (HCL): 2nd largest university hospital in France, with over 22,000 staff
- One of the largest concentrations of university hospitals in Europe
- Almost 32,000 beds in the public and private sectors
- 36,000 people employed
News
- Biovision 2013: world most prominent life sciences experts expected at the world life sciences forum in Lyon (22/03/13)
- Biovision 2013: Biovision Investor Conference, 330 million euro cumulative fund raising by the 35 selected companies (22/03/13)
- Edelris: launch of the European lead factory in February 2013 (08/03/13)
Project call
Related files
- Accinov : communiqué de presse de la pose de la 1re pierre du 5 juillet 2012 (PDF - 152 Ko)
- Accinov : dossier de presse de la plateforme d'innovation du 5 juillet 2012 (PDF - 1.6 Mo)
- CLARA: progress report 2010 (french version) (PDF - 8.5 Mo)
- CLARA: progress report 2010 (PDF - 6.4 Mo)
- Lyon Gerland : dossier de presse "présentation des projets du Biopôle" du 25 mars 2013 (PDF - 4.1 Mo)









